Correlation Between Iovance Biotherapeutics and Palatin Technologies
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Palatin Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Palatin Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Palatin Technologies, you can compare the effects of market volatilities on Iovance Biotherapeutics and Palatin Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Palatin Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Palatin Technologies.
Diversification Opportunities for Iovance Biotherapeutics and Palatin Technologies
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Iovance and Palatin is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Palatin Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palatin Technologies and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Palatin Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palatin Technologies has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Palatin Technologies go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Palatin Technologies
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.8 times more return on investment than Palatin Technologies. However, Iovance Biotherapeutics is 1.25 times less risky than Palatin Technologies. It trades about 0.05 of its potential returns per unit of risk. Palatin Technologies is currently generating about -0.01 per unit of risk. If you would invest 549.00 in Iovance Biotherapeutics on September 14, 2024 and sell it today you would earn a total of 227.00 from holding Iovance Biotherapeutics or generate 41.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Palatin Technologies
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Palatin Technologies |
Iovance Biotherapeutics and Palatin Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Palatin Technologies
The main advantage of trading using opposite Iovance Biotherapeutics and Palatin Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Palatin Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palatin Technologies will offset losses from the drop in Palatin Technologies' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Palatin Technologies vs. Puma Biotechnology | Palatin Technologies vs. Iovance Biotherapeutics | Palatin Technologies vs. Day One Biopharmaceuticals | Palatin Technologies vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |